Ira Glenn Schulman

Title: Ira Glenn Schulman: Innovator in LXR Ligand Research

Introduction

Ira Glenn Schulman is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of LXR ligands. With a total of 2 patents, his work focuses on methods that have the potential to impact metabolic diseases and cardiovascular health.

Latest Patents

Schulman's latest patents include a method for LXR ligand testing. This method allows for the easy measurement of whether an LXR ligand can affect plasma triglyceride concentration and/or LDL cholesterol concentration in mammals. It utilizes the binding activity between LXR and a coactivator. Another significant patent involves methods for affecting various diseases using LXR compounds. This invention relates to elevating HDL plasma levels, decreasing dietary cholesterol absorption, and treating conditions such as type II diabetes and obesity through the use of LXR selective agonists and antagonists.

Career Highlights

Throughout his career, Schulman has worked with prominent companies in the pharmaceutical industry. He has been associated with X-ceptor Therapeutics, Inc. and Daiichi Sankyo Company, Limited. His work in these organizations has contributed to advancements in drug development and therapeutic methods.

Collaborations

Schulman has collaborated with notable professionals in his field, including Eric D. Bischoff and Rajendra K. Tangirala. These collaborations have further enhanced his research and innovation in LXR ligand applications.

Conclusion

Ira Glenn Schulman is a distinguished inventor whose work in LXR ligands has the potential to transform treatments for metabolic diseases and cardiovascular conditions. His contributions continue to influence the field of biochemistry and pharmaceutical research.